Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Can immune biomarkers predict benefit from targeted agents in metastatic renal cell carcinoma?

Pichler R, Schmidinger M.

Ann Transl Med. 2019 Dec;7(Suppl 8):S275. doi: 10.21037/atm.2019.11.138. No abstract available.

2.

Molecular Basis for Autosomal-Dominant Renal Fanconi Syndrome Caused by HNF4A.

Marchesin V, Pérez-Martí A, Le Meur G, Pichler R, Grand K, Klootwijk ED, Kesselheim A, Kleta R, Lienkamp S, Simons M.

Cell Rep. 2019 Dec 24;29(13):4407-4421.e5. doi: 10.1016/j.celrep.2019.11.066.

3.

Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Pichler R, Lindner AK, Compérat E, Obrist P, Schäfer G, Todenhöfer T, Horninger W, Culig Z, Untergasser G.

Am J Pathol. 2020 Feb;190(2):442-452. doi: 10.1016/j.ajpath.2019.10.018. Epub 2019 Dec 13.

4.

Drug-Drug Interactions in Prostate Cancer Treatment.

Hebenstreit D, Pichler R, Heidegger I.

Clin Genitourin Cancer. 2019 May 27. pii: S1558-7673(19)30154-5. doi: 10.1016/j.clgc.2019.05.016. [Epub ahead of print] Review.

PMID:
31677899
5.

Impact of Diabetic Stress Conditions on Renal Cell Metabolome.

Lagies S, Pichler R, Bork T, Kaminski MM, Troendle K, Zimmermann S, Huber TB, Walz G, Lienkamp SS, Kammerer B.

Cells. 2019 Sep 24;8(10). pii: E1141. doi: 10.3390/cells8101141.

6.

Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.

Heidegger I, Pircher A, Pichler R.

Front Oncol. 2019 Jun 14;9:490. doi: 10.3389/fonc.2019.00490. eCollection 2019. Review.

7.

Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.

Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M.

Clin Genitourin Cancer. 2019 Oct;17(5):e957-e967. doi: 10.1016/j.clgc.2019.05.017. Epub 2019 May 25.

8.

68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers.

Calabria F, Pichler R, Leporace M, Wolfsgruber J, Coscarelli P, Dunzinger A, Schillaci O, Cascini GL, Bagnato A.

Curr Radiopharm. 2019;12(3):238-246. doi: 10.2174/1874471012666190515090755.

PMID:
31113354
9.

Rare, but Severe: Vasculitis and Checkpoint Inhibitors.

Lindner AK, Gruenbacher G, Schachtner G, Thurnher M, Pichler R.

Eur Urol Focus. 2019 May 6. pii: S2405-4569(19)30130-0. doi: 10.1016/j.euf.2019.04.014. [Epub ahead of print] Review.

PMID:
31072806
10.

Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.

Lindner AK, Schachtner G, Steiner E, Kroiss A, Uprimny C, Steinkohl F, Horninger W, Heidegger I, Madersbacher S, Pichler R.

World J Urol. 2020 Feb;38(2):417-424. doi: 10.1007/s00345-019-02793-9. Epub 2019 May 6.

11.

Albumin in Cirrhosis: More Than a Colloid.

Paine CH, Biggins SW, Pichler RH.

Curr Treat Options Gastroenterol. 2019 Jun;17(2):231-243. doi: 10.1007/s11938-019-00227-4. Review.

PMID:
30968341
12.

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?

Pichler R, Compérat E, Klatte T, Pichler M, Loidl W, Lusuardi L, Schmidinger M.

Cancers (Basel). 2019 Mar 25;11(3). pii: E422. doi: 10.3390/cancers11030422.

13.

Effect of Process Parameters and High-Temperature Preheating on Residual Stress and Relative Density of Ti6Al4V Processed by Selective Laser Melting.

Malý M, Höller C, Skalon M, Meier B, Koutný D, Pichler R, Sommitsch C, Paloušek D.

Materials (Basel). 2019 Mar 20;12(6). pii: E930. doi: 10.3390/ma12060930.

14.

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.

J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15.

PMID:
30875280
15.

Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?

Lindner AK, Klatte T, Comperat E, Heidegger I, Pichler R.

Urol Oncol. 2019 Jun;37(6):343-345. doi: 10.1016/j.urolonc.2019.02.001. Epub 2019 Feb 28. No abstract available.

PMID:
30826167
16.

Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol 2019;75:853-60.

Pichler R, Heidegger I.

Eur Urol. 2019 Jun;75(6):e175-e176. doi: 10.1016/j.eururo.2019.02.016. Epub 2019 Feb 23. No abstract available.

PMID:
30803730
17.

High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.

Pichler R, Loidl W, Pichler M.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S738-S740. doi: 10.21037/tau.2018.08.15. No abstract available.

18.

Cholesterol pathway the Achilles heel in prostate cancer metastasis.

Heidegger I, Pichler R, Pircher A.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S686-S687. doi: 10.21037/tau.2018.08.12. No abstract available.

19.

Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.

Pircher A, Schäfer G, Eigentler A, Pichler R, Puhr M, Steiner E, Horninger W, Gunsilius E, Klocker H, Heidegger I.

Int J Med Sci. 2019 Jan 1;16(1):115-124. doi: 10.7150/ijms.28735. eCollection 2019.

21.

Short review of biparametric prostate MRI.

Steinkohl F, Pichler R, Junker D.

Memo. 2018;11(4):309-312. doi: 10.1007/s12254-018-0458-1. Epub 2018 Nov 12. Review.

22.

ASCO 2018: highlights of urothelial cancer and prostate cancer.

Pichler R, Horninger W, Heidegger I.

Memo. 2018;11(4):284-290. doi: 10.1007/s12254-018-0422-0. Epub 2018 Jul 24. Review.

23.

Fabrication of Kidney Proximal Tubule Grafts Using Biofunctionalized Electrospun Polymer Scaffolds.

Jansen K, Castilho M, Aarts S, Kaminski MM, Lienkamp SS, Pichler R, Malda J, Vermonden T, Jansen J, Masereeuw R.

Macromol Biosci. 2019 Feb;19(2):e1800412. doi: 10.1002/mabi.201800412. Epub 2018 Dec 13.

PMID:
30548802
24.

Visibility of MRI prostate lesions on B-mode transrectal ultrasound.

Steinkohl F, Luger AK, Pichler R, Bektic J, Rehder P, Lebovici A, Aigner F.

Med Ultrason. 2018 Dec 8;20(4):441-445. doi: 10.11152/mu-1602.

25.

Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report.

Lindner AK, Schachtner G, Tulchiner G, Staudacher N, Steinkohl F, Nguyen VA, Horninger W, Pichler R.

Urol Case Rep. 2018 Nov 15;23:1-2. doi: 10.1016/j.eucr.2018.11.008. eCollection 2019 Mar. No abstract available.

26.

Treatment of Hyponatremia in End-Stage Liver Disease: New Tools in the Shed.

Paine CH, Pichler RH.

Am J Gastroenterol. 2018 Nov;113(11):1728-1729. doi: 10.1038/s41395-018-0269-3. No abstract available.

PMID:
30323267
27.

Protecting kidneys in liver transplant patients: A pathway to preventive interventions.

Sibulesky L, Biggins SW, Pichler R.

World J Hepatol. 2018 Sep 27;10(9):637-638. doi: 10.4254/wjh.v10.i9.637.

28.

[Symptomatic urinary obstruction in patients with metastatic malignancies].

Heidegger I, Steinkohl F, Horninger W, Pichler R.

Aktuelle Urol. 2018 Sep;49(5):422-428. doi: 10.1055/a-0658-0790. Epub 2018 Sep 5. Review. German.

PMID:
30184601
29.

Antidiabetic drugs influence molecular mechanisms in prostate cancer.

Pircher A, Zieher M, Eigentler A, Pichler R, Schäfer G, Fritz J, Puhr M, Steiner E, Horninger W, Klocker H, Heidegger I.

Cancer Biol Ther. 2018;19(12):1153-1161. doi: 10.1080/15384047.2018.1491490. Epub 2018 Aug 1.

30.

A rare case of a 123I-MIBG SPECT/CT positive, but 68Ga-DOTA-TOC PET/CT negative pheochromocytoma of the bladder.

Kroiss AS, Uprimny C, Pichler R, Gasser RW, Virgolini IJ.

Rev Esp Med Nucl Imagen Mol. 2018 Sep - Oct;37(5):315-317. doi: 10.1016/j.remn.2018.02.001. Epub 2018 Jul 2. English, Spanish.

PMID:
30042056
31.

Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients.

Pichler R, Fritz J, Lackner F, Sprung S, Brunner A, Horninger W, Loidl W, Pircher A, Heidegger I.

Clin Genitourin Cancer. 2018 Oct;16(5):e1015-e1024. doi: 10.1016/j.clgc.2018.05.015. Epub 2018 Jun 8.

PMID:
29960831
32.

Serotonin 1A receptor density measured by F18-Mefway PET/CT in mesiotemporal cortex and raphe does not discriminate therapeutic response in patients with major depressive episode.

Barth M, Dunzinger A, Wimmer I, Winkler J, Rittmannsberger H, Nader M, Pichler R.

Q J Nucl Med Mol Imaging. 2018 Jun 14. doi: 10.23736/S1824-4785.18.03039-X. [Epub ahead of print]

PMID:
29916219
33.

Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial.

Heidegger I, Pichler R, Heidenreich A, Horninger W, Pircher A.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S132-S134. doi: 10.21037/tau.2017.10.06. No abstract available.

34.

High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.

Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R.

Cancer Sci. 2018 May;109(5):1583-1591. doi: 10.1111/cas.13560. Epub 2018 Apr 16.

35.

Metabolic characterization of directly reprogrammed renal tubular epithelial cells (iRECs).

Lagies S, Pichler R, Kaminski MM, Schlimpert M, Walz G, Lienkamp SS, Kammerer B.

Sci Rep. 2018 Mar 1;8(1):3878. doi: 10.1038/s41598-018-22073-7.

36.

Bovine monocyte derived dendritic cell based assay for measuring vaccine immunogenicity in vitro.

Kangethe RT, Pichler R, Chuma FNJ, Cattoli G, Wijewardana V.

Vet Immunol Immunopathol. 2018 Mar;197:39-48. doi: 10.1016/j.vetimm.2018.01.009. Epub 2018 Jan 31.

PMID:
29475505
37.

Influence of Scanning Strategies on Processing of Aluminum Alloy EN AW 2618 Using Selective Laser Melting.

Koutny D, Palousek D, Pantelejev L, Hoeller C, Pichler R, Tesicky L, Kaiser J.

Materials (Basel). 2018 Feb 14;11(2). pii: E298. doi: 10.3390/ma11020298.

38.

Construction of two whole genome radiation hybrid panels for dromedary (Camelus dromedarius): 5000RAD and 15000RAD.

Perelman PL, Pichler R, Gaggl A, Larkin DM, Raudsepp T, Alshanbari F, Holl HM, Brooks SA, Burger PA, Periasamy K.

Sci Rep. 2018 Jan 31;8(1):1982. doi: 10.1038/s41598-018-20223-5.

39.

Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound.

Pichler R, Tulchiner G, Steinkohl F, Soleiman A, Horninger W, Heidegger IM, Aigner F.

Eur J Med Res. 2018 Jan 11;23(1):3. doi: 10.1186/s40001-018-0301-5.

40.

Limits of Schema Mappings.

Kolaitis PG, Pichler R, Sallinger E, Savenkov V.

Theory Comput Syst. 2018;62(4):899-940. doi: 10.1007/s00224-017-9812-7. Epub 2017 Oct 2.

41.

Renal rupture - Not what it seems.

Pichler R, Heidegger I, Schachtner G, Stuehmeier J, Agaimy A, Maier H, Glodny B, Rehder P.

Urol Case Rep. 2017 Dec 6;16:132-134. doi: 10.1016/j.eucr.2017.11.033. eCollection 2018 Jan. No abstract available.

42.

Novel concepts of antiangiogenic therapies in metastatic renal cell cancer.

Pichler R, Heidegger I.

Memo. 2017;10(4):206-212. doi: 10.1007/s12254-017-0344-2. Epub 2017 Aug 11. Review.

43.

Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.

Pichler R, Fritz J, Heidegger I, Oberaigner W, Horninger W, Hochleitner M.

J Cancer. 2017 Sep 30;8(17):3567-3574. doi: 10.7150/jca.21130. eCollection 2017.

44.

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.

Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I.

Int J Mol Sci. 2017 Oct 31;18(11). pii: E2291. doi: 10.3390/ijms18112291. Review.

45.

Uptake of 68Ga-Prostate-Specific Membrane Antigen PET in Adrenal Gland: A Potential Pitfall.

Strele-Trieb P, Dunzinger A, Sonnberger M, Wolfsgruber J, Pichler R.

Clin Nucl Med. 2018 Jan;43(1):50-51. doi: 10.1097/RLU.0000000000001881.

PMID:
29076912
46.

A hybrid, low-cost tissue-like epidural needle insertion simulator.

Esterer B, Gabauer S, Pichler R, Wirthl D, Drack M, Hollensteiner M, Kettlgruber G, Kaltenbrunner M, Bauer S, Furst D, Merwa R, Meier J, Augat P, Schrempf A.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:42-45. doi: 10.1109/EMBC.2017.8036758.

PMID:
29059806
47.

PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.

Pichler R, Heidegger I, Fritz J, Danzl M, Sprung S, Zelger B, Brunner A, Pircher A.

Oncotarget. 2017 Aug 3;8(40):66849-66864. doi: 10.18632/oncotarget.19913. eCollection 2017 Sep 15.

48.

Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.

Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, Klocker H, Heidegger I.

BJU Int. 2018 Jan;121(1):29-37. doi: 10.1111/bju.14019. Epub 2017 Oct 12.

49.

Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.

Pichler R, Tulchiner G, Fritz J, Schaefer G, Horninger W, Heidegger I.

Int J Med Sci. 2017 Jul 19;14(9):811-819. doi: 10.7150/ijms.19929. eCollection 2017.

50.

Instant tough bonding of hydrogels for soft machines and electronics.

Wirthl D, Pichler R, Drack M, Kettlguber G, Moser R, Gerstmayr R, Hartmann F, Bradt E, Kaltseis R, Siket CM, Schausberger SE, Hild S, Bauer S, Kaltenbrunner M.

Sci Adv. 2017 Jun 21;3(6):e1700053. doi: 10.1126/sciadv.1700053. eCollection 2017 Jun.

Supplemental Content

Loading ...
Support Center